Peter Friedli

This is a page dedicated to get more information for investors to evaluate the management style of Peter Friedli who is a Co-Founder and Chairman of Osiris Therapeutics.

Here on this page we are inviting all readers to discuss Peter Friedli. You may anonymously post comments with any information that they have about Peter Friedli. You can post comments about their management style or whatever you want to talk about concerning their ability as an executive. Please refrain from personal attacks.

Here is a copy of personal Bio that we found:

Mr. Friedli also arranged the placement through a European investment bank of a $20.6 million convertible promissory note in late fall 2005. In connection with all of these transactions, an aggregate of $71.9 million in gross proceeds was raised for us. We paid referral fees and costs of $3.4 million to accounts designated by Mr. Friedli, including accounts of third parties unrelated to Mr. Friedli. We also paid expense reimbursement of $350 to Mr. Friedli and issued 12,500 shares of our common stock to him in recognition of his fundraising efforts on our behalf in 2004 and 2005. In addition, specific to the placement of the $20.6 million convertible promissory note, we paid placement agency fees to the European investment bank.